Study to Assess the Effect of Leucine Along With Resistance Exercise on Muscle Strength and Quality of Life in Elders
NCT ID: NCT00929929
Last Updated: 2014-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2009-12-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Leucine Supplementation in Young Subjects Undergoing Resistance Training
NCT02744443
Leucine Supplementation in Elderly Men
NCT00807508
Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women
NCT01922167
Leucine Supplementation and Skeletal Muscle Disuse
NCT01192009
Effect of Carnitine Supplementation and Resistance Training on Skeletal Muscle Function
NCT03907592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In any population of autonomous individuals over 65 years, a proportion between 3% and 32% depending on age, meets the criteria of the so-called Frailty Syndrome. Frailty is characterized by a decrease in reserves and resistance to aggression, conferring increased vulnerability, disability and poor vital prognosis.
A feature of the Frailty Syndrome is the potential reversibility of many of the elements at the initial stages of frailty. Currently, available treatment for frailty is limited. One of the tools should be the prevention of sarcopenia, where nutritional treatment and exercise have a vital role.
Protein synthesis in aged muscle can be improved by increasing leucine concentration above physiological levels by a higher intake. Regarding exercise, progressive resistance training is one of the interventions that have shown better results in the increase of mass and muscle strength in elderly people.
The hypothesis raises the possibility that an intervention consisting of a leucine supplement along with progressive resistance training, is superior to the same training program and a placebo in improving muscle strength and quality of life in elderly people.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-Leucine
This arm receives a supplement of leucine along with a progressive resistance exercise program.
L-leucine.
10 g of leucine per day, during 12 weeks.
Exercise program.
Progressive resistance exercise program 4 days a week, during 12 weeks.
Maltodextrin
This arm receives a supplement of maltodextrin along with a progressive resistance exercise program.
Maltodextrin.
10 g of maltodextrin per day, during 12 weeks.
Exercise program.
Progressive resistance exercise program 4 days a week, during 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-leucine.
10 g of leucine per day, during 12 weeks.
Maltodextrin.
10 g of maltodextrin per day, during 12 weeks.
Exercise program.
Progressive resistance exercise program 4 days a week, during 12 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects capable of doing resistance exercise.
Exclusion Criteria
* Disabled patients (i.e., not being able to exercise).
* Patients that usually train in resistance exercise.
* Patients with chronic renal failure.
* Patients with a fractured extremity during the last 6 months.
* Patients that follow diets with a protein restriction.
* Patients with oral nutritional support, enteral or parenteral nutrition.
* Patients in a low calorie diet to lose weight.
* Patients using pharmacological treatment with anorexigenic effects, anabolic steroids or corticosteroids.
* Patients with cognitive impairment or major psychiatric disorder.
* Non-signed informed consent.
* Any patient not capable to properly follow the treatment or not considered adequate by the researchers.
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pere Leyes
Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria T Forga, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Clinic of Barcelona
Joan Trabal, RD, MS
Role: STUDY_CHAIR
Hospital Clinic of Barcelona
Pere Leyes, MD
Role: STUDY_CHAIR
Hospital Clinic of Barcelona
Andreu Farran, PhD
Role: STUDY_CHAIR
University of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nutrition and Dietetics Unit, Hospital ClĂnic de Barcelona
Barcelona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.
Related Links
Access external resources that provide additional context or updates about the study.
A brief definition of the Frailty Syndrome.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FRA_LEU-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.